Literature DB >> 11678424

Increased human polo-like kinase-1 expression in gliomas.

K Dietzmann1, E Kirches, K Jachau, C Mawrin.   

Abstract

PLK-1 (polo-like kinase) belongs to the family of serine/threonine kinases and is involved in spindle formation, centrosome cycles and chromosome segregation. Hence, the kinase is tightly linked to cell proliferation. We could detect immunohistochemically highly expressed PLK protein in astrocytic tumours depending on the grade of anaplasia, in commercially available human glioma cell lines (U87MG, U118MG, U138MG), in one immortalized cell culture derived from a glioblastoma patient and in a primary culture derived from a glioblastoma patient. The highest labelling of PLK-1 was demonstrated in glioblastomas. There was a significant correlation between the PLK expression and the nuclear immunoreactivity of MIB-1. PLK-mRNA, found in all tumour specimens investigated emphasizes the close correlation to proliferation and growth. Furthermore, the relation of the PLK-1 expression to the Mitogen-activated Protein Kinase Cascades was studied by applying various highly specific inhibitors. While all inhibitors minimized the cell density, only the PLCy inhibitor clearly lead to a reduced PLK-1 expression in the three cell lines U87MG, U118MG, U138MG.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11678424     DOI: 10.1023/a:1011808200978

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  33 in total

Review 1.  Protein kinases in control of the centrosome cycle.

Authors:  T Mayor; P Meraldi; Y D Stierhof; E A Nigg; A M Fry
Journal:  FEBS Lett       Date:  1999-06-04       Impact factor: 4.124

2.  Prognostic value of pololike kinase expression in melanomas.

Authors:  K Strebhardt; L Kneisel; C Linhart; A Bernd; R Kaufmann
Journal:  JAMA       Date:  2000-01-26       Impact factor: 56.272

Review 3.  Polo-like kinases: a team that plays throughout mitosis.

Authors:  D M Glover; I M Hagan; A A Tavares
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

Review 4.  The family of polo-like kinases.

Authors:  R M Golsteyn; H A Lane; K E Mundt; L Arnaud; E A Nigg
Journal:  Prog Cell Cycle Res       Date:  1996

Review 5.  The MAPK signaling cascade.

Authors:  R Seger; E G Krebs
Journal:  FASEB J       Date:  1995-06       Impact factor: 5.191

6.  Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck.

Authors:  R Knecht; R Elez; M Oechler; C Solbach; C von Ilberg; K Strebhardt
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

7.  Cell cycle regulation of the human polo-like kinase (PLK) promoter.

Authors:  T Uchiumi; D L Longo; D K Ferris
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

8.  Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors.

Authors:  U Holtrich; G Wolf; A Bräuninger; T Karn; B Böhme; H Rübsamen-Waigmann; K Strebhardt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

Review 9.  Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

Authors:  C J Marshall
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

10.  Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes.

Authors:  H A Lane; E A Nigg
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

View more
  28 in total

1.  Clinical significance of Polycomb gene expression in brain tumors.

Authors:  Francesco Crea; Elaine M Hurt; William L Farrar
Journal:  Mol Cancer       Date:  2010-09-30       Impact factor: 27.401

2.  PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide.

Authors:  Fumi Higuchi; Alexandria L Fink; Juri Kiyokawa; Julie J Miller; Mara V A Koerner; Daniel P Cahill; Hiroaki Wakimoto
Journal:  Mol Cancer Ther       Date:  2018-09-14       Impact factor: 6.261

Review 3.  Satellite Cells in Muscular Dystrophy - Lost in Polarity.

Authors:  Natasha C Chang; Fabien P Chevalier; Michael A Rudnicki
Journal:  Trends Mol Med       Date:  2016-05-05       Impact factor: 11.951

4.  Plk1-mediated stabilization of 53BP1 through USP7 regulates centrosome positioning to maintain bipolarity.

Authors:  H Yim; S-B Shin; S U Woo; P C-W Lee; R L Erikson
Journal:  Oncogene       Date:  2016-08-01       Impact factor: 9.867

5.  Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.

Authors:  Wilko Weichert; Glen Kristiansen; Klaus-Jürgen Winzer; Mathias Schmidt; Volker Gekeler; Aurelia Noske; Berit-Maria Müller; Silvia Niesporek; Manfred Dietel; Carsten Denkert
Journal:  Virchows Arch       Date:  2005-03-23       Impact factor: 4.064

6.  ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT.

Authors:  Kate Marie Lewis; Claudia Petritsch
Journal:  Transl Neurosci       Date:  2013-12       Impact factor: 1.757

7.  Apoptosis induction with polo-like kinase-1 antisense phosphorothioate oligodeoxynucleotide of colon cancer cell line SW480.

Authors:  Yu Fan; Shu Zheng; Ze-Feng Xu; Jia-Yi Ding
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

8.  Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells.

Authors:  Robin G Lerner; Stefan Grossauer; Banafsheh Kadkhodaei; Ian Meyers; Maxim Sidorov; Katharina Koeck; Rintaro Hashizume; Tomoko Ozawa; Joanna J Phillips; Mitchel S Berger; Theodore Nicolaides; C David James; Claudia K Petritsch
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

9.  Differential expression of centrosomal proteins at different stages of human glioma.

Authors:  Joon-Khim Loh; Ann-Shung Lieu; Chia-Hua Chou; Fang-Yi Lin; Chia-Hung Wu; Sheng-Long Howng; Chung-Ching Chio; Yi-Ren Hong
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

10.  Inhibition of polo-like kinase 1 induces cell cycle arrest and sensitizes glioblastoma cells to ionizing radiation.

Authors:  Julia Alejandra Pezuk; María Sol Brassesco; Andressa Gois Morales; Jaqueline Carvalho de Oliveira; Harley Francisco de Oliveira; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Cancer Biother Radiopharm       Date:  2013-05-28       Impact factor: 3.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.